Home
Company
Therapeutic Focus
Pipeline
UNI-494
Renazorb
Investors
Resources
Contact
Financial Results
Investors
Investors
Overview
News
Events & Presentations
IR Calendar
Presentations
Governance
Overview
Management Team
Board of Directors
Board Committees
Governance Documents
SEC Filings
Overview
All SEC Filings
Annual Reports
Quarterly Reports
Section 16 Filings
Financial & Stock Info
Overview
Financial Results
Quote
Charts
Historical Data
Analyst Coverage
Resources
Overview
Contacts
FAQ
Email Alerts
2024
Q3 2024
Quarter Ended Sep 30, 2024
Earnings Release
PDF
HTML
10-Q
Filing
PDF
HTML
XBRL
ZIP
XLS
HTML
Q2 2024
Quarter Ended Jun 30, 2024
Earnings Release
PDF
HTML
10-Q
Filing
PDF
HTML
XBRL
ZIP
XLS
HTML
Q1 2024
Quarter Ended Mar 31, 2024
Earnings Release
PDF
HTML
10-Q
Filing
PDF
HTML
XBRL
ZIP
XLS
HTML
2023
FY 2023
Fiscal Year Ended Dec 31, 2023
Earnings Release
PDF
HTML
10-K
Filing
PDF
HTML
XBRL
ZIP
XLS
HTML
Q3 2023
Quarter Ended Sep 30, 2023
Earnings Release
PDF
HTML
10-Q
Filing
PDF
HTML
XBRL
ZIP
XLS
HTML
Q2 2023
Quarter Ended Jun 30, 2023
Earnings Release
PDF
HTML
10-Q
Filing
PDF
HTML
XBRL
ZIP
XLS
HTML
Q1 2023
Quarter Ended Mar 31, 2023
Earnings Release
PDF
HTML
10-Q
Filing
PDF
HTML
XBRL
ZIP
XLS
HTML
2022
FY 2022
Fiscal Year Ended Dec 31, 2022
Earnings Release
PDF
HTML
10-K
Filing
PDF
HTML
XBRL
ZIP
XLS
HTML
Q3 2022
Quarter Ended Sep 30, 2022
Earnings Release
PDF
HTML
10-Q
Filing
PDF
HTML
XBRL
ZIP
XLS
HTML
Q2 2022
Quarter Ended Jun 30, 2022
Earnings Release
PDF
HTML
10-Q
Filing
PDF
HTML
XBRL
ZIP
XLS
HTML
Q1 2022
Quarter Ended Mar 31, 2022
Earnings Release
PDF
HTML
10-Q
Filing
PDF
HTML
XBRL
ZIP
XLS
HTML
2021
FY 2021
Fiscal Year Ended Dec 31, 2021
Earnings Release
PDF
HTML
10-K
Filing
PDF
HTML
XBRL
ZIP
XLS
HTML
Q3 2021
Quarter Ended Sep 30, 2021
Earnings Release
PDF
HTML
10-Q
Filing
PDF
HTML
XBRL
ZIP
XLS
HTML
Q2 2021
Quarter Ended Jun 30, 2021
Earnings Release
PDF
HTML
10-Q
Filing
PDF
HTML
XBRL
ZIP
XLS
HTML
Email Alerts
Contacts
RSS News Feed